Carter Bankshares Reports Strong 2025 Earnings Growth and New $10M Share Buyback Amidst Persistent Large Nonperforming Loan
summarizeSummary
Carter Bankshares reported a 28% increase in net income and a 30% rise in diluted EPS for 2025, alongside a new $10.0 million share repurchase authorization, but faces ongoing challenges with a concentrated $214.0 million nonaccrual loan.
check_boxKey Events
-
Strong Financial Performance
Net income increased 28% to $31.4 million for the year ended December 31, 2025, with diluted earnings per share rising 30% to $1.38. Net interest income grew 14.3% to $130.8 million, and net interest margin expanded to 2.82%.
-
Improved Asset Quality Metrics
Nonperforming loans (NPLs) decreased by $15.4 million to $244.0 million, improving NPLs as a percentage of total portfolio loans to 6.29% from 7.15%. Net charge-offs significantly declined to $0.5 million in 2025 from $16.4 million in 2024.
-
New Share Repurchase Program Authorized
The company fully utilized its $20.0 million share repurchase program in 2025 and authorized a new $10.0 million program on February 2, 2026, signaling continued capital management and shareholder returns.
-
Persistent Large Nonperforming Loan
The largest credit relationship, totaling $214.0 million, remains on nonaccrual status and represents 87.7% of total NPLs. While $38.0 million in curtailment payments were received in 2025, this loan continues to be a significant credit risk, with allowance for credit losses covering only 29.30% of NPLs.
auto_awesomeAnalysis
Carter Bankshares, Inc. delivered strong financial results for 2025, with significant increases in net income and diluted EPS, driven by improved net interest income and margin. The company also made progress in reducing overall nonperforming loans and net charge-offs, and demonstrated a commitment to shareholder returns by fully utilizing a $20.0 million share repurchase program and authorizing a new $10.0 million program. However, a critical concern remains the single largest credit relationship, totaling $214.0 million, which continues to be on nonaccrual status and represents a substantial portion (87.7%) of total nonperforming loans. The allowance for credit losses to nonperforming loans remains low at 29.30%, indicating limited coverage for potential future losses on these troubled assets. Investors should monitor the ongoing resolution of this large loan and its potential impact on future asset quality and profitability.
At the time of this filing, CARE was trading at $20.70 on NASDAQ in the Finance sector, with a market capitalization of approximately $457.1M. The 52-week trading range was $13.61 to $22.51. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.